ID: ALA289813

Max Phase: Preclinical

Molecular Formula: C19H16FNO3S

Molecular Weight: 357.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c(C=O)cc(-c2ccc(S(C)(=O)=O)cc2)n1-c1ccc(F)cc1

Standard InChI:  InChI=1S/C19H16FNO3S/c1-13-15(12-22)11-19(21(13)17-7-5-16(20)6-8-17)14-3-9-18(10-4-14)25(2,23)24/h3-12H,1-2H3

Standard InChI Key:  ZGCJSQLGNBMGHW-UHFFFAOYSA-N

Associated Targets(Human)

Cyclooxygenase-2 13999 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclooxygenase-1 9233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclooxygenase-1 661 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclooxygenase-2 1939 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 357.41Molecular Weight (Monoisotopic): 357.0835AlogP: 3.81#Rotatable Bonds: 4
Polar Surface Area: 56.14Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.40CX LogD: 3.40
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.67Np Likeness Score: -1.45

References

1. Khanna IK, Weier RM, Yu Y, Collins PW, Miyashiro JM, Koboldt CM, Veenhuizen AW, Currie JL, Seibert K, Isakson PC..  (1997)  1,2-Diarylpyrroles as potent and selective inhibitors of cyclooxygenase-2.,  40  (11): [PMID:9171872] [10.1021/jm970036a]
2. Chavatte P, Yous S, Marot C, Baurin N, Lesieur D..  (2001)  Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.,  44  (20): [PMID:11563921] [10.1021/jm0101343]
3. Battilocchio C, Poce G, Alfonso S, Porretta GC, Consalvi S, Sautebin L, Pace S, Rossi A, Ghelardini C, Di Cesare Mannelli L, Schenone S, Giordani A, Di Francesco L, Patrignani P, Biava M..  (2013)  A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity.,  21  (13): [PMID:23680444] [10.1016/j.bmc.2013.04.031]

Source